Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6330-6337

  Housseau, Franck ^a   Bright, Robert K ^a,c   Simonis, Toni ^b   Nishimura, Michael I ^a   Topalian, Suzanne L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Robert W Franz Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BREFELDIN A; CD1 ANTIGEN; CD8 ANTIGEN; CHLOROQUINE; CYCLOHEXIMIDE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOLOGY; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ANTIGEN PRESENTATION; ANTIGENS, CD1; ANTIGENS, NEOPLASM; BETA 2-MICROGLOBULIN; CARCINOMA; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; COLONIC NEOPLASMS; CYSTEINE ENDOPEPTIDASES; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIENZYME COMPLEXES; PROSTATIC NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0033485423     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Boon, T. 1993. Tumor antigens recognized by cytolylic T lymphocytes: present perspectives for specific immunotherapy. Int. J. Cancer 54:177.
2. Pardoll, D. M. 1998. Cancer vaccines. Nat. Med. 4:525.
3. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, N. P. Restifo, M. E. Dudley, S. L. Schwarz, P. J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321.
4. Jager, E., M. Ringhoffer, H. P. Dienes, M. Arand, J. Karbach, D. Jager, C. Ilsemann, M. Hagedorn, F. Oesch, and A. Knuth. 1996. Granulocyte-macrophage-colony-stitnulating factor enhances immune responses to melanoma-associated peplides in vivo. Int. J. Cancer 67:54.
5. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328.
6. + T cells in the antitumor immune response. J. Exp. Med. 188:2357.
7. + T cell responses in antitumor immunity. Curr. Opin. Immunol. 10:588.
8. Griffeths, E., H. Ong, M. J. Soloski, M. F. Bachmann, P. S. Ohashi, and D. E. Speiser. 1998. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I. Cancer Res. 58:4682.
9. Garnick, M. B., and W. R. Fair. 1998. Combating prostate cancer. Sci. Am. 279:674.
10. Bright, R. K., C. D. Vocke, M. R. Emmert-Buck, P. H. Duray, D. Solomon, P. Fetsch, J. S. Rhim, M. Linehan, and S. L. Topalian. 1997. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res. 57:995.
11. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer 58:69.
12. + T cells. J. Exp. Med 189:757.
13. Schwarzentruber, D. J., S. L. Topalian, M. Mancini, and S. A. Rosenberg. 1991. Specific release of GM-CSF, TNF-α and IFN-γ by human tumor-infiltrating lymphocytes following autologous tumor stimulation. J. Immunol. 146:3674.
14. Nishimura, M. I., Y. Kawakami, P. Charmley, B. O'Neil, J. Shilyansky, J. R. Yannelli, S. A. Rosenberg, and L. Hood. 1994. T cell receptor repertoire in tumor infiltrating lymphocytes: analysis of melanoma-specific long-term lines. J. Immunother. 16:85.
15. Kirszenbaum, M., P. Moreau, E. Gluckman, J. Dausset, and E. Carosella. 1994. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. USA 91:4209.
16. O'Neil, B.H., Y. Kawakami, N. P. Restifo, J. R. Bennink, J. W. Yewdell, and S. A. Rosenberg. 1993. Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-medicated transduction of genes coding for HLA. J. Immunol. 151:1410.
17. - T Cells. J. Exp. Med. 186: 109 .
18. O'Callahan, C. A., and J. I. Bell. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163:129.
19. Bendelac, A. 1995. CD1: Presenting unusual antigens to unusual T lymphocytes. Science 269:185.
20. Sieling, P. A., D. Chatterjee, S. A. Porcelli, T. I. Prigozy, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, and R. L. Modlin. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227.
21. Travers, P. J., J. L. Arklie, J. Trowsdale, R. A. Patillo, and W. F. Bodmer. 1982. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. Natl. Cancer Inst. Monogr. 60:175.
22. 2-micoglobulin expression. Scand. J. Immunol. 30:21.
23. Braud, V. M., D. S.-J. Allan, and A. J. McMichael. 1999. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11: 100.
24. Blumberg, R. S., C. Terhorst, R. Bleicher, F. V. McDermott. C. H. Allan, S. B. Landau, J. S. Trier, and S. P. Balk. 1991. Expression of a nonpolymorphic MHC class I-like molecule. CD1D, by human intestinal epithelial cells. J. Immunol. 147:2518.
25. Mandelboim, O., L. Pazmany, D. M. Davis, M. Vales-Gomez, H. T. Reyburn, B. Rybalov, and J. L. Strominger. 1997. Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 94:14666.
26. Diehl, M., C. Munz, W. Keilholz, S. Stevanovic, N. Holmes, Y. W. Loke, and H.-G. Rammensee. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6:305.
27. Lee, N., A. R. Malacko, A. Ishitani, M.-C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:59.
28. Barnd, D. L., M. S. Lan, R. S. Metzgar, and O. J. Finn. 1989. Specific, major histocompatibility complex-unrestricted recognition of tumor associated mucins by human cytotoxic T cells. Proc Natl. Acad. Sci. USA 86:7159.
29. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, F. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521.
30. Castano, A. R., S. Tangri, J. E. W. Miller, H. R. Holcombe, M. R. Jackson, W. D. Huse, M. Kronenberg, and P. A. Peterson. 1995. Peptide binding and presentation by mouse CD1. Science 269:223.
31. Lee, D. J., A. Abeyratne, D. A. Carson, and M. Corr. 1998. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response in vivo. J. Exp. Med. 187:433.
32. Parham, P. 1996. Keeping mother at bay. Curr. Biol. 6:638.
33. Pascale, P., N. Rouas-Freiss, I. Khalil-Daher, P. Moreau, B. Riteau, F. A. Le Gal, M. F. Avril, J. Dausset, J. G. Guillet, and E. D. Carosella. 1998. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc. Natl. Acad. Sci. USA 95:4510.
34. Lee, N., M. Llano, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A. Immunology 95:5199.
35. Braud, V. M., D. S. J. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795.
36. Martinozzi, S., R. Pacasova, H.-J. Boulouis, M. Ulbrecht, E. H. Weiss, F. Sigaux, and M. Pla. 1999. Requirement of class I signal sequence-derived peptides for HLA-E recognition by a mouse cytotoxic T cell clone. J. Immunol. 162:5662.
37. Hashimoto, K., M. Hirai, and Y. Kurosawa. 1995. A gene outside the human MHC related to classical HLA class I genes. Science 269:693.
38. Li, P., S. T. Willie, S. Bauer, D. L. Morris, T. Spies, and R. K. Strong. 1999. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand Immunity 10:577.
39. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
40. Robbins, P. F., and Y. Kawakami. 1996. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:628.